APOTHECA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHECA
Largest movements
- Receivables after one year +€205,323
up €205,323 (+640%), from €32,100 to €237,423
- Cash -€187,940
down €187,940 (-97.5%), from €192,720 to €4,780
mainly Receivables after one year (-€205,323) and Trade debts (-€17,187)
- Receivables within one year +€8,664
up €8,664 (+36.1%), from €23,976 to €32,639
of which Trade receivables: +€4,571
- Other debts +€75,000
up €75,000 (+556%), from €13,500 to €88,500
- Trade debts -€17,187
down €17,187 (-75.9%), from €22,637 to €5,450
- Tax, wage and social debts -€16,172
down €16,172 (-57.5%), from €28,147 to €11,975
- Profit (loss) carried forward -€14,244
down €14,244 (-8.0%), from €178,492 to €164,248
- Gross operating margin -€74,205
down €74,205, from €73,658 to -€547
- Taxes -€9,473
down €9,473 (-99.9%), from €9,486 to €12
- Depreciation -€2,040
down €2,040 (-58.6%), from €3,481 to €1,441
- Other operating charges +€1,629
up €1,629 (+21.5%), from €7,562 to €9,191
- Financial charges -€1,181
down €1,181 (-27.9%), from €4,233 to €3,052
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €258,897 | €286,294 | +€27,397 | +10.6% |
| Fixed assets | 21/28 | €9,241 | €7,800 | -€1,441 | -15.6% |
| Tangible fixed assets | 22/27 | €1,441 | - | -€1,441 | |
| Furniture and vehicles | 24 | €1,441 | - | -€1,441 | |
| Financial fixed assets | 28 | €7,800 | €7,800 | = | 0.0% |
| Current assets | 29/58 | €249,656 | €278,494 | +€28,838 | +11.6% |
| Amounts receivable after more than one year | 29 | €32,100 | €237,423 | +€205,323 | +640% |
| Trade receivables | 290 | €32,100 | €237,423 | +€205,323 | +640% |
| Amounts receivable within one year | 40/41 | €23,976 | €32,639 | +€8,664 | +36.1% |
| Trade receivables | 40 | - | €4,571 | +€4,571 | |
| Other amounts receivable | 41 | €23,976 | €28,068 | +€4,092 | +17.1% |
| Cash at bank and in hand | 54/58 | €192,720 | €4,780 | -€187,940 | -97.5% |
| Deferred charges and accrued income | 490/1 | €860 | €3,652 | +€2,792 | +325% |
| Total equity and liabilities | 10/49 | €258,897 | €286,294 | +€27,397 | +10.6% |
| Equity | 10/15 | €194,613 | €180,369 | -€14,244 | -7.3% |
| Contributions | 10/11 | €16,121 | €16,121 | = | 0.0% |
| Capital | 10 | €16,121 | €16,121 | = | 0.0% |
| Issued capital | 100 | €18,521 | €18,521 | = | 0.0% |
| Uncalled capital | 101 | €2,400 | €2,400 | = | 0.0% |
| Profit (loss) carried forward | 14 | €178,492 | €164,248 | -€14,244 | -8.0% |
| Amounts payable | 17/49 | €64,284 | €105,925 | +€41,641 | +64.8% |
| Amounts payable within one year | 42/48 | €64,284 | €105,925 | +€41,641 | +64.8% |
| Trade debts | 44 | €22,637 | €5,450 | -€17,187 | -75.9% |
| Suppliers | 440/4 | €22,637 | €5,450 | -€17,187 | -75.9% |
| Taxes, remuneration and social security | 45 | €28,147 | €11,975 | -€16,172 | -57.5% |
| Taxes | 450/3 | €28,147 | €11,975 | -€16,172 | -57.5% |
| Other amounts payable | 47/48 | €13,500 | €88,500 | +€75,000 | +556% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,481 | €1,441 | -€2,040 | -58.6% |
| Other operating charges | 640/8 | €7,562 | €9,191 | +€1,629 | +21.5% |
| Gross operating margin | 9900 | €73,658 | -€547 | -€74,205 | |
| Operating profit (loss) | 9901 | €62,616 | -€11,179 | -€73,795 | |
| Financial charges | 65/66B | €4,233 | €3,052 | -€1,181 | -27.9% |
| Recurring financial charges | 65 | €4,233 | €3,052 | -€1,181 | -27.9% |
| Profit (loss) for the period before taxes | 9903 | €58,383 | -€14,231 | -€72,614 | |
| Income taxes | 67/77 | €9,486 | €12 | -€9,473 | -99.9% |
| Profit (loss) for the period | 9904 | €48,897 | -€14,244 | -€63,141 | |
| Profit (loss) for the period to be appropriated | 9905 | €48,897 | -€14,244 | -€63,141 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.